Annovis Bio, Inc. (ANVS) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Mar 13, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Annovis Bio, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Annovis Bio, Inc.'s filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-32.94%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Annovis Bio, Inc. actually do?
Answer:
Annovis Bio is a late-stage clinical drug platform company focused on neurodegenerative diseases, primarily Alzheimer's (AD) and Parkinson's (PD). Its lead candidate, buntanetap, is an orally administered small molecule designed to inhibit the synthesis of neurotoxic proteins implicated in neurodegeneration, such as APP, tau, and alpha-synuclein. The company is currently conducting a pivotal Phase 3 study for early AD and an open-label extension study for PD, with plans for a Parkinson's disease dementia study. Annovis aims to develop buntanetap as a disease-modifying therapy that can restore nerve cell function and potentially be the first drug to improve both cognition in AD and motor function in PD.
Question:
What are Annovis Bio, Inc.'s revenue drivers?
Answer:
The company has not generated any product revenues and does not anticipate generating revenues for the foreseeable future. Its primary focus is on the development and potential commercialization of its product candidates.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required